AMAG Pharma (NASDAQ: AMAG) reported Q3 EPS of ($0.70), $0.04 worse than the analyst estimate of ($0.66). Revenue ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE